In the last few years lncRNAs have gained increasing attention among the scientific community, thanks to the discovery of their implication in many physio-pathological processes. In particular, their contribution to tumor initiation, progression, and response to treatment has attracted the interest of experts in the oncologic field for their potential clinical application. Testicular cancer is one of the tumors in which lncRNAs role is emerging. Said malignancies already have very effective treatments, which although lead to the development of quite serious treatment-related conditions, such as secondary tumors, infertility, and cardiovascular diseases. It is therefore important to study the impact of lncRNAs in the tumorigenesis of testicular cancer in order to learn how to exploit them in a clinical setting and to substitute more toxic treatments. Eventually, the use of lncRNAs as biomarkers, drug targets, or therapeutics for testicular cancer may represent a valid alternative to that of conventional tools, leading to a better management of this malignancy and its related conditions, and possibly even to the treatment of poor prognosis cases.
Long Non-Coding RNAs: Role in Testicular Cancers / C. Bresesti, V. Vezzoli, B. Cangiano, M. Bonomi. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 11(2021 Mar 09).
|Titolo:||Long Non-Coding RNAs: Role in Testicular Cancers|
BONOMI, MARCO (Ultimo) (Corresponding)
|Parole Chiave:||testis cancer; testicular germ-cell tumors; seminomas; non-seminomas; hypogonadism;|
|Settore Scientifico Disciplinare:||Settore MED/13 - Endocrinologia|
|Data di pubblicazione:||9-mar-2021|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.3389/fonc.2021.605606|
|Appare nelle tipologie:||01 - Articolo su periodico|